Kansas SB284 prohibits manufacturers from interfering with 340B drug distribution by requiring health information or data from covered entities.
Kansas SB284, known as the Defense of Drug Delivery Act, aims to protect the 340B drug pricing program by prohibiting manufacturers from requiring health information or data from covered entities as a condition for receiving 340B drugs. This includes information such as health claims, purchasing data, and other specified data. The act allows the attorney general to investigate violations and impose civil penalties of up to $50,000 per violation. It also establishes the Defense of Drug Delivery Fund to manage fines and penalties collected under the act.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.